
(PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 — /EuropaWire/ — Life science, health care and nutrition global enterprise Bayer announced that the leading global open-access biologics technology firm WuXi Biologics (WuXi Bio), listed in Hong Kong (stock code: 2269.HK), through its subsidiary in … Read the full press release